-- Surgery 2 Question Bank: Topic 22 - Chronic Arterial Occlusion (33 MCQs)
-- Category: Surgery 2 (a0000002-0000-0000-0000-000000000002)
-- Topic: Chronic Arterial Occlusion (c0000022-0000-0000-0000-000000000022)

INSERT INTO questions (topic_id, category_id, question_text, option_a, option_b, option_c, option_d, option_e, correct_option, explanation, difficulty, cognitive_level) VALUES
('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'The most common cause of peripheral arterial disease is:', 'Vasculitis', 'Atherosclerosis', 'Embolism', 'Thromboangiitis obliterans', 'Trauma', 'B', 'Atherosclerosis accounts for >95% of chronic peripheral arterial disease. Risk factors include smoking, diabetes, hypertension, hyperlipidemia, and age.', 'easy', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'The most important modifiable risk factor for peripheral arterial disease is:', 'Age', 'Smoking', 'Gender', 'Family history', 'Race', 'B', 'Smoking is the most important modifiable risk factor, increasing PAD risk 2-4 fold. Smoking cessation is the single most important intervention to slow disease progression.', 'easy', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Intermittent claudication is defined as:', 'Constant leg pain', 'Muscle pain induced by exercise and relieved by rest', 'Night pain in limbs', 'Pain at rest', 'Numbness in feet', 'B', 'Claudication: muscle pain/cramping during walking, relieved within 2-5 minutes of rest, reproducible at similar distance. Most commonly affects calf (SFA disease).', 'easy', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'The Fontaine classification Stage II refers to:', 'Asymptomatic', 'Intermittent claudication', 'Rest pain', 'Gangrene', 'Acute ischemia', 'B', 'Fontaine classification: Stage I (asymptomatic), Stage II (claudication), Stage III (rest pain), Stage IV (ulceration/gangrene). Stages III-IV = critical limb ischemia.', 'medium', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Critical limb ischemia is defined by:', 'Claudication at 500 meters', 'Rest pain, ulceration, or gangrene threatening limb viability', 'Normal ABI', 'Mild claudication', 'Asymptomatic disease', 'B', 'Critical limb ischemia (CLI): rest pain requiring analgesia >2 weeks, non-healing wounds, or gangrene. Ankle pressure <50-70 mmHg or toe pressure <30-50 mmHg.', 'medium', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Rest pain in critical limb ischemia is characteristically:', 'Worst during exercise', 'Worse at night and relieved by dependency', 'Relieved by elevation', 'Located in hip and thigh', 'Absent', 'B', 'Rest pain: typically affects forefoot/toes, worse at night (horizontal position reduces perfusion pressure), relieved by dependency (hanging leg over bed).', 'medium', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'The ankle-brachial index (ABI) is calculated by:', 'Dividing brachial pressure by ankle pressure', 'Dividing highest ankle pressure by highest brachial pressure', 'Adding ankle and brachial pressures', 'Subtracting brachial from ankle pressure', 'Multiplying pressures together', 'B', 'ABI = highest ankle pressure (DP or PT) / highest brachial pressure. Normal 0.9-1.3. Mild PAD 0.7-0.9. Moderate 0.4-0.7. Severe <0.4.', 'easy', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'An ABI of 0.5 indicates:', 'Normal circulation', 'Mild disease', 'Moderate to severe disease', 'No arterial disease', 'Venous disease', 'C', 'ABI 0.4-0.7 indicates moderate-severe PAD. Usually symptomatic with claudication. CLI typically has ABI <0.4. Values >1.3 suggest non-compressible calcified arteries.', 'medium', 'application'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Non-compressible ankle arteries (ABI >1.3) are commonly seen in:', 'Young healthy individuals', 'Diabetics and patients with renal failure due to medial calcification', 'Venous disease', 'Acute ischemia', 'Normal elderly', 'B', 'Medial arterial calcification (Monckeberg sclerosis) in diabetes and CKD causes arteries to be non-compressible, giving falsely elevated ABI. Toe pressures are more reliable.', 'medium', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'For diabetic patients with non-compressible vessels, the best test is:', 'Repeat ABI', 'Toe-brachial index (TBI)', 'Venous duplex', 'CT head', 'ECG', 'B', 'TBI: toe pressure/brachial pressure. Digital arteries are rarely calcified. Normal TBI >0.7. TBI <0.25 indicates CLI. More accurate in diabetic/CKD patients.', 'medium', 'application'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Duplex ultrasound in PAD evaluates:', 'Bone density', 'Arterial anatomy, stenosis severity, and blood flow velocity', 'Nerve conduction', 'Venous insufficiency only', 'Muscle mass', 'B', 'Duplex: combines B-mode imaging (anatomy) with Doppler (flow). Peak systolic velocity ratio >2.5 indicates >50% stenosis; >4.0 suggests >75% stenosis.', 'medium', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'CT angiography for PAD provides:', 'Functional information only', 'Detailed anatomical information of arterial tree for planning intervention', 'No useful information', 'Only venous anatomy', 'Bone density measurement', 'B', 'CTA: excellent anatomical detail, non-invasive, fast. Shows stenosis location/severity, calcification, collaterals. Requires contrast and radiation. Standard for planning revascularization.', 'easy', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Medical management of claudication includes all EXCEPT:', 'Smoking cessation', 'Statin therapy', 'Supervised exercise program', 'Immediate bypass surgery', 'Antiplatelet therapy', 'D', 'Medical management: smoking cessation, exercise therapy, risk factor modification (statins, BP control, diabetes control), antiplatelet therapy. Surgery only for failed medical therapy or CLI.', 'easy', 'application'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Supervised exercise therapy for claudication involves:', 'Bed rest', 'Walking to near-maximal claudication pain, rest, and repeat for 30-60 minutes', 'Swimming only', 'Upper body exercises', 'Avoiding all walking', 'B', 'Supervised exercise: walk until near-maximal pain, rest until resolved, repeat. 30-60 min sessions, 3x/week, for 3+ months. Improves walking distance by 150-200%.', 'medium', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Cilostazol works by:', 'Blocking calcium channels', 'Inhibiting phosphodiesterase III causing vasodilation and antiplatelet effect', 'Blocking beta receptors', 'Increasing blood viscosity', 'Inhibiting clotting factors', 'B', 'Cilostazol: PDE3 inhibitor, causes vasodilation and inhibits platelet aggregation. Improves claudication distance. Contraindicated in heart failure.', 'medium', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Indications for revascularization in PAD include:', 'All claudicants', 'Lifestyle-limiting claudication failing medical therapy or critical limb ischemia', 'Asymptomatic disease', 'ABI >0.9', 'Mild claudication', 'B', 'Revascularization indications: disabling claudication not responding to medical therapy (>3 months), critical limb ischemia (rest pain, tissue loss), acute limb ischemia.', 'medium', 'application'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Endovascular treatment options for PAD include:', 'Bypass surgery only', 'Angioplasty, stenting, and atherectomy', 'Medication only', 'Amputation', 'Compression therapy', 'B', 'Endovascular: balloon angioplasty, stent placement (bare-metal, drug-eluting), drug-coated balloons, atherectomy (rotational, laser, orbital). First-line for many lesions.', 'easy', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'TASC II classification of aortoiliac disease Type D lesions are best treated by:', 'Angioplasty alone', 'Surgical bypass', 'Medical therapy only', 'Compression stockings', 'Exercise only', 'B', 'TASC II: Type A (short focal lesions, endovascular preferred), Type D (extensive disease, surgery preferred). Type B/C have less clear-cut recommendations.', 'hard', 'application'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Aortobifemoral bypass is indicated for:', 'Isolated SFA disease', 'Extensive aortoiliac occlusive disease', 'Popliteal aneurysm', 'Venous insufficiency', 'Diabetic foot ulcer', 'B', 'Aortobifemoral bypass: gold standard for extensive bilateral aortoiliac disease. Excellent durability (5-year patency 85-90%). Major surgery with associated morbidity.', 'medium', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'The preferred conduit for infrainguinal bypass is:', 'Prosthetic graft', 'Autogenous saphenous vein', 'Dacron', 'Bovine carotid artery', 'Arm vein only', 'B', 'Great saphenous vein is preferred for all infrainguinal bypass (especially below-knee). Superior patency and infection resistance compared to prosthetic grafts.', 'easy', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Femoropopliteal bypass with prosthetic graft is acceptable when:', 'Always preferred', 'Target is above-knee popliteal and no vein available', 'Always for below-knee targets', 'Vein is always available', 'Never acceptable', 'B', 'Prosthetic grafts (PTFE, Dacron) are acceptable for above-knee femoropopliteal bypass when vein not available. Patency is inferior to vein, especially for below-knee targets.', 'medium', 'application'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Leriche syndrome is characterized by:', 'Unilateral leg claudication', 'Buttock and thigh claudication, impotence, and absent femoral pulses', 'Arm claudication', 'Abdominal angina', 'Digital ischemia', 'B', 'Leriche syndrome: aortoiliac occlusive disease causing bilateral buttock/thigh claudication, erectile dysfunction, and absent/diminished femoral pulses.', 'medium', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Superficial femoral artery disease most commonly causes:', 'Buttock claudication', 'Calf claudication', 'Foot claudication', 'Thigh claudication', 'No symptoms', 'B', 'SFA disease causes calf claudication as calf muscles (gastrocnemius, soleus) supplied by popliteal/tibial arteries are underperfused during exercise.', 'easy', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Aortoiliac disease causes claudication in:', 'Calf only', 'Buttock, hip, and thigh', 'Foot only', 'Hand', 'Upper extremity', 'B', 'Aortoiliac disease: buttock, hip, and thigh claudication. If bilateral with impotence = Leriche syndrome. Also diminished femoral pulses.', 'easy', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Infrainguinal bypass graft surveillance is performed to:', 'Monitor blood pressure', 'Detect graft stenosis before thrombosis occurs', 'Check wound healing only', 'Assess cardiac function', 'Monitor renal function', 'B', 'Graft surveillance with duplex identifies stenoses before graft thrombosis. Peak systolic velocity ratio >3.0 or low graft velocity indicates significant stenosis requiring intervention.', 'medium', 'application'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Patients with PAD have increased risk of:', 'Osteoporosis', 'Cardiovascular events (MI, stroke) and death', 'Gallstones', 'Kidney stones', 'Appendicitis', 'B', 'PAD is a marker of systemic atherosclerosis. 5-year mortality is 25-30% mainly from cardiac and cerebrovascular events. CV risk reduction is paramount.', 'easy', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Antiplatelet therapy in PAD is indicated to:', 'Improve claudication symptoms', 'Reduce cardiovascular morbidity and mortality', 'Treat rest pain', 'Heal ulcers directly', 'Reduce ABI', 'B', 'Antiplatelet therapy (aspirin, clopidogrel) reduces cardiovascular events (MI, stroke, vascular death) in PAD patients. All symptomatic PAD patients should receive it.', 'medium', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Statin therapy in PAD patients is recommended to:', 'Target LDL only if >200', 'Reduce CV events and improve outcomes regardless of baseline cholesterol', 'Only for hyperlipidemia', 'Improve walking distance directly', 'Treat leg pain', 'B', 'High-intensity statins reduce CV events in PAD. Target LDL <70 mg/dL or >50% reduction. All PAD patients benefit from statins regardless of baseline cholesterol.', 'medium', 'application'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Buerger disease (thromboangiitis obliterans) differs from atherosclerotic PAD by:', 'Affecting older patients', 'Affecting young male smokers with small vessel involvement and superficial thrombophlebitis', 'Being more common', 'Having high cholesterol', 'Affecting only large vessels', 'B', 'Buerger disease: young men (<45), heavy smokers, small and medium vessel involvement, superficial thrombophlebitis, Raynauds. Must stop smoking completely.', 'medium', 'knowledge'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Amputation level determination considers:', 'Patient preference only', 'Tissue viability, perfusion, and functional rehabilitation potential', 'Only wound appearance', 'Surgeon convenience', 'Insurance coverage', 'B', 'Amputation level: adequate perfusion for healing, maximal functional length preservation, rehabilitation potential. Transcutaneous oxygen (TcPO2) >30 mmHg suggests healing.', 'hard', 'application'),

('c0000022-0000-0000-0000-000000000022'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Natural history of claudication shows that most patients:', 'Progress to amputation within 1 year', 'Remain stable or improve with conservative management', 'All require surgery', 'All develop rest pain', 'None respond to exercise', 'B', 'Natural history: 70-80% remain stable or improve with risk factor modification and exercise. Only 10-15% progress to CLI; 1-2% annual amputation risk.', 'medium', 'knowledge');
